GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (FRA:ZSB) » Definitions » Additional Paid-In Capital

Sirona Biochem (FRA:ZSB) Additional Paid-In Capital : €5.14 Mil(As of Jan. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sirona Biochem Additional Paid-In Capital?


Sirona Biochem's quarterly additional paid-in capital increased from Jul. 2023 (€5.02 Mil) to Oct. 2023 (€5.06 Mil) and increased from Oct. 2023 (€5.06 Mil) to Jan. 2024 (€5.14 Mil).

Sirona Biochem's annual additional paid-in capital increased from Oct. 2021 (€4.54 Mil) to Oct. 2022 (€5.42 Mil) but then declined from Oct. 2022 (€5.42 Mil) to Oct. 2023 (€5.06 Mil).

Sirona Biochem Additional Paid-In Capital Historical Data

The historical data trend for Sirona Biochem's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Biochem Additional Paid-In Capital Chart

Sirona Biochem Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.45 4.22 4.54 5.42 5.06

Sirona Biochem Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.07 4.96 5.02 5.06 5.14

Sirona Biochem Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Sirona Biochem Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Sirona Biochem's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Sirona Biochem (FRA:ZSB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (FRA:ZSB) » Definitions » Additional Paid-In Capital
Comparable Companies
TSX:RVX TSX:ATE XCNQ:BETR TSX:AEZS XCNQ:ASEP XCNQ:PREV TSXV:KNE XCNQ:MDMA XCNQ:PHRM XCNQ:BIOV OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
SRBCF:USA ZSB:Germany SBM:Canada
Address
C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L3
Website
https://www.sironabiochem.com
Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. It has a business presence in Canada and France.

Sirona Biochem (FRA:ZSB) Headlines

No Headlines